ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 226 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,393,600 | -53.3% | 544,000 | -39.6% | 0.78% | -46.2% |
| Q2 2023 | $41,549,291 | -51.3% | 900,700 | -57.7% | 1.45% | -48.7% |
| Q1 2023 | $85,288,690 | -38.4% | 2,126,900 | -28.9% | 2.83% | -5.7% |
| Q4 2022 | $138,526,700 | +63.1% | 2,990,000 | +45.7% | 3.00% | +73.8% |
| Q3 2022 | $84,957,000 | -3.7% | 2,051,600 | +38.7% | 1.73% | -14.8% |
| Q2 2022 | $88,267,000 | +39.9% | 1,479,500 | +70.3% | 2.03% | +54.2% |
| Q1 2022 | $63,107,000 | +7.2% | 869,000 | +24.1% | 1.31% | +5.3% |
| Q4 2021 | $58,863,000 | +43.4% | 700,000 | +53.8% | 1.25% | +37.3% |
| Q3 2021 | $41,036,000 | – | 455,000 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |